Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
49 - 60 of 349 Results
Sort by:
Best Match
Technical Note
Opera Phenix Plus high-content screening system: crosstalk suppression
Technical note describing how fluorescent crosstalk is suppressed by the Opera Phenix Plus high-content screening system.
Literature - Publication Review
Morphological profiling of human T and NK lymphocytes by high-content imaging
The study in this publication review provides a foundation for the development of morphological profiling as a scalable approach to monitor the immune synapse (IS), primary lymphocyte responsiveness and microarchitecture.
Literature - Publication Review
Multifunctional mRNA-based CAR T-cells show promising anti-tumor activity against glioblastoma
Learn how researchers have evaluated the efficiency of mRNA-based multifunctional CAR T-cells against glioblastoma in vitro and in vivo.
Literature - Publication Review
Imaging and gene editing approaches highlight important role of autophagy in controlling Mtb infection
Learn how researchers used CRISPR-Cas9 gene editing and high-content imaging approaches to explore the role of autophagy in controlling Mtb infection.
Case Study
A scalable method to monitor protein levels and localizations in cells
Pooled protein tagging, cellular imaging, and in-situ sequencing to identify cellular response to drug treatment.
Application Note
Measuring FRET using the Opera™ Phenix™ high-content screening system
Here, we present a FRET-based high-content screening assay to study the interaction of the anti-apoptotic protein Bcl-XL with the pro-apoptotic protein Bad.
Application Note
Imaging bile canaliculi in 3D liver microtissues
Here, we describe a 3D HCS assay to study hepatobiliary transporter function in InSphero human liver microtissues using the Opera Phenix™ HCS system.
Whitepaper
A brand-new modality on the horizon: how targeted protein degradation can address the unmet need in drug discovery and development
Discover the potential of Targeted Protein Degradation (TPD) as an emerging drug discovery modality. Explore how TPD enables the selective targeting and degradation of proteins, even those previously considered "undruggable."
Webinar
wbs-discover-advanced-high-throughput-dna-extraction-techniques-for-population-studies-prime-ceph
Discover automated high-throughput DNA extraction for large-scale genomic studies and benefit from expert experiences. Watch this webinar now!
Webinar
Large scale drug combination screening - Finding the needle in the haystack
Watch this on-demand webinar to learn about Revvity's cell panel screening platform and its application for large scale oncology drug combination screening.
Webinar
OncoSignature™ Long-term assay: Extending the reach of cell panel screens
Learn about the OncoSignature™ long-term assay service and the advantages it can have for characterizing slower acting or epigenetic drugs in this on-demand webinar.
Literature - Publication Review
The impact of pan-KRAS inhibitors on cancer drug discovery
Read how Boehringer Ingelheim generated compounds to target the "undruggable" KRAS pathway with the help of Revvity's preclinical services.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.